Triple

T12588568
Position Surface form Disambiguated ID Type / Status
Subject Ruth Arnon E300536 entity
Predicate coDeveloperOf P6901 FINISHED
Object Copaxone
Copaxone is a disease-modifying immunotherapy drug used to treat relapsing forms of multiple sclerosis by reducing the frequency of flare-ups.
 E993287 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Copaxone | Statement: [Ruth Arnon, coDeveloperOf, Copaxone]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Copaxone
Context triple: [Ruth Arnon, coDeveloperOf, Copaxone]
  • A. Tysabri
    Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
  • B. Tecfidera
    Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
  • C. fingolimod
    Fingolimod is an oral disease-modifying immunomodulatory drug used to reduce relapses and delay disability progression in people with relapsing forms of multiple sclerosis.
  • D. Rinvoq
    Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
  • E. Remicade
    Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Copaxone
Triple: [Ruth Arnon, coDeveloperOf, Copaxone]
Generated description
Copaxone is a disease-modifying immunotherapy drug used to treat relapsing forms of multiple sclerosis by reducing the frequency of flare-ups.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Copaxone
Target entity description: Copaxone is a disease-modifying immunotherapy drug used to treat relapsing forms of multiple sclerosis by reducing the frequency of flare-ups.
  • A. Tysabri
    Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
  • B. Tecfidera
    Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
  • C. fingolimod
    Fingolimod is an oral disease-modifying immunomodulatory drug used to reduce relapses and delay disability progression in people with relapsing forms of multiple sclerosis.
  • D. Rinvoq
    Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
  • E. Remicade
    Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d7bde87b648190bcd0266e9efde098 completed April 9, 2026, 2:55 p.m.
NER Named-entity recognition batch_69d954bd5e8c8190a2f233b91682341f completed April 10, 2026, 7:51 p.m.
NED1 Entity disambiguation (via context triple) batch_69f65ec0a60c8190948706e8b2fcc0ad completed May 2, 2026, 8:29 p.m.
NEDg Description generation batch_69f662cc2a208190870e2099a8bb5d04 completed May 2, 2026, 8:47 p.m.
NED2 Entity disambiguation (via description) batch_69f6638319d48190ba73480ce6e91d83 completed May 2, 2026, 8:50 p.m.
Created at: April 9, 2026, 5:06 p.m.